Journal profile · Infectious Diseases
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
ISSN 0213-005X · eISSN 1578-1852 · Ediciones Doyma, S.L. · SPAIN · Monthly · Founded 1984
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.09; hybrid open access; APC about USD 2,280; review about 79 days (submission to acceptance, publisher); community-reported acceptance: easy; 142 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is published by Ediciones Doyma, S.L. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pneumonia and Respiratory Infections, Bacterial Identification and Susceptibility Testing and Antifungal resistance and susceptibility, together about 17.8% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
The journal Enfermedades Infecciosas y Microbiología Clínica is the official publication of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) (Spanish Society of Infectious Diseases and Clinical Microbiology). It has as its aim to respond to the challenges currently posed by everything associated with infectious diseases, from a clinical, microbiological and public health perspective.The journal follows a rigorous selection process of the manuscripts published through the review by the best experts in each area of knowledge of the specialty. The quality of the material published is the main aim of the Editors, as well as to provide readers with the latest and most relevant information in the world of infectious diseases.Enfermedades Infecciosas y Microbiología Clínica includes the following sections: original articles, critical reviews, scientific letters and consensus documents. The journal accepts articles in Spanish and English.The journal is included in Science Citation Index Expanded, Medline/PubMed, and SCOPUS.La revista Enfermedades Infecciosas y Microbiología Clínica es el órgano de expresión de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) (Spanish Society of Infectious Diseases and Clinical Microbiology), tiene como objetivo dar respuesta a los retos que actualmente plantea todo lo relacionado con la patología infecciosa, desde el punto de vista clínico, microbiológico y de salud pública.La revista sigue un riguroso proceso de selección de los manuscritos publicados a través de la revisión por los mejores expertos en cada una áreas de conocimiento de la especialidad. Los editores tienen como principal objetivo asegurar la calidad de los materiales publicados, así como proporcionar a los lectores la información más relevante y de última hora en el mundo de la infectología.Entre las secciones de Enfermedades Infecciosas y Microbiología Clínica destacan: artículos originales, revisiones críticas, cartas científicas y documentos de consenso. La revista aceptaartículos en español y en inglés.La revista está incluida en Science Citation Index Expanded, Medline/Pubmed y SCOPUS.
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Editor-in-chief David Navarro OrtegaPublisher website
Editorial board by country: none in mainland China; most named Spain 35, Italy 3, Colombia 3, Peru 2 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pneumonia and Respiratory InfectionsMedicine6.2%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology6.2%
- Antifungal resistance and susceptibilityMedicine5.4%
- Streptococcal Infections and TreatmentsMedicine5.2%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology5.2%
- HIV/AIDS Research and InterventionsMedicine5.2%
- Nosocomial Infections in ICUMedicine4.9%
- Antibiotic Use and ResistanceImmunology and Microbiology4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Microbiology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.09LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher)
- 2.4Publisher website ·
- SJR 2026-06
- 0.39LetPub ·
- SNIP 2026-06
- 0.44LetPub ·
- h-index
- 40LetPub ·
- h-index
- 56OpenAlex ·
- i10-index
- 1,219OpenAlex ·
- 2-year mean citedness
- 0.75OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 15.79%LetPub ·
Volume
- Articles per year
- 94LetPub ·
Articles by year OpenAlex count · 5,546 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 157 | 28 | 21 |
| 2025 | 142 | 20 | 101 |
| 2024 | 150 | 24 | 214 |
| 2023 | 100 | 15 | 184 |
| 2022 | 153 | 42 | 467 |
| 2021 | 194 | 61 | 787 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
79 dayssubmission to acceptance · community reports 6–12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 32%Publisher website ·
- Submission to first decision
- 10 daysPublisher website ·
- First decision after review
- 36 daysPublisher website ·
- Submission to acceptance
- 79 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,280 / EUR 2,130 / GBP 1,830 / JPY 282,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3, with length limits
- editorialdocument that has been accepted by the editorial committee, with a maximum length of 3,000 words. In addition, an unstructured abstract will be submitted inmain text ≤ 3,000 words
- originalsOriginals. Prospective works of clinical, pharmacological or microbiological research will be admitted, as well as original contributions on the aetiology, phys…Length not stated
- reviewAny article submitted to this journal must follow the guidelines outlined in the "Ethics and Policies" section of this author’s guide. It is essential to consul…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page from the Journal Homepage for more information.
Source ↗Publisher website ·- Peer review
Double anonymized review Model summary
This journal uses double anonymized review, which means the identities of the authors are concealed from the reviewers, and vice versa.
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Ediciones Doyma, S.L.
- Country or region
- SPAIN
- Language
- Spanish
- Frequency
- Monthly
- Founded
- 1984
- ISSN
- 0213-005X
- Electronic ISSN
- 1578-1852
- Society / sponsor
- Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
What CAS zone is ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA in?
In the 2025 upgraded edition of the CAS Journal Ranking, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is in Zone 4 of Medicine, and in Zone 4 of the minor category Infectious Diseases / Microbiology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA?
The latest impact factor listed by LetPub is 2.09; CiteScore 2.4, h-index 56.
How long does peer review take at ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA?
The publisher reports about 79 days (submission to acceptance); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 32%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA based?
Of the 43 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Spain (35), Italy (3) and Colombia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA?
According to LetPub and DOAJ records, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is indexed in SCIE and Scopus. The journal's website also lists MEDLINE and PubMed; that list has not been checked against each database.
Is ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA open access, and what is the APC?
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a hybrid journal. For open-access publication: APC about USD 2,280.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .